These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 35476182

  • 21. Precise Dissolution Control and Bioavailability Evaluation for Insoluble Drug Berberine via a Polymeric Particle Prepared Using Supercritical CO₂.
    Jia J, Zhang K, Zhou X, Zhou D, Ge F.
    Polymers (Basel); 2018 Oct 26; 10(11):. PubMed ID: 30961123
    [Abstract] [Full Text] [Related]

  • 22. Natural Nano-Drug Delivery System in Coptidis Rhizoma Extract with Modified Berberine Hydrochloride Pharmacokinetics.
    Zhao J, Zhao Q, Lu JZ, Ye D, Mu S, Yang XD, Zhang WD, Ma BL.
    Int J Nanomedicine; 2021 Oct 26; 16():6297-6311. PubMed ID: 34552326
    [Abstract] [Full Text] [Related]

  • 23. In Vitro and In Vivo Evaluations of Berberine-Loaded Microparticles Filled In-House 3D Printed Hollow Capsular Device for Improved Oral Bioavailability.
    Choudhury D, Jala A, Murty US, Borkar RM, Banerjee S.
    AAPS PharmSciTech; 2022 Mar 16; 23(4):89. PubMed ID: 35296955
    [Abstract] [Full Text] [Related]

  • 24. Nanocrystal-Loaded Lipid Carriers for Improved Oral Absorption and Anticancer Efficacy of Etoposide: Formulation Development, Transport Mechanism, In Vitro and In Vivo Evaluation.
    Wang Y, Wang P, Li H, Han X, Zhu H, Jin X.
    Mol Pharm; 2024 Mar 04; 21(3):1170-1181. PubMed ID: 38329909
    [Abstract] [Full Text] [Related]

  • 25. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
    Zhaojie M, Ming Z, Shengnan W, Xiaojia B, Hatch GM, Jingkai G, Li C.
    Int J Pharm; 2014 Jun 05; 467(1-2):50-9. PubMed ID: 24607213
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effect of crystal size on the in vitro dissolution and oral absorption of nitrendipine in rats.
    Xia D, Cui F, Piao H, Cun D, Piao H, Jiang Y, Ouyang M, Quan P.
    Pharm Res; 2010 Sep 05; 27(9):1965-76. PubMed ID: 20585842
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Rod-shaped nintedanib nanocrystals improved oral bioavailability through multiple intestinal absorption pathways.
    Zhu Y, Fu Y, Zhang A, Wang X, Zhao Z, Zhang Y, Yin T, Gou J, Wang Y, He H, Tang X.
    Eur J Pharm Sci; 2022 Jan 01; 168():106047. PubMed ID: 34687899
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes.
    Chen M, Li W, Zhang X, Dong Y, Hua Y, Zhang H, Gao J, Zhao L, Li Y, Zheng A.
    Int J Nanomedicine; 2017 Jan 01; 12():5487-5500. PubMed ID: 28814865
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Formulation, optimization, and in vitro-in vivo evaluation of olmesartan medoxomil nanocrystals.
    Jain S, Patel K, Arora S, Reddy VA, Dora CP.
    Drug Deliv Transl Res; 2017 Apr 01; 7(2):292-303. PubMed ID: 28116656
    [Abstract] [Full Text] [Related]

  • 36. Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine.
    Buchanan B, Meng Q, Poulin MM, Zuccolo J, Azike CG, Gabriele J, Baranowski DC.
    PLoS One; 2018 Apr 01; 13(3):e0194979. PubMed ID: 29579096
    [Abstract] [Full Text] [Related]

  • 37. Characterization and Bioavailability Study of Baicalin-mesoporous Carbon Nanopowder Solid Dispersion.
    Cui L, Sune E, Song J, Wang J, Jia XB, Zhang ZH.
    Pharmacogn Mag; 2016 Apr 01; 12(48):326-332. PubMed ID: 27867277
    [Abstract] [Full Text] [Related]

  • 38. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.
    Zhang Z, Chen Y, Deng J, Jia X, Zhou J, Lv H.
    Int J Pharm; 2014 Apr 25; 465(1-2):306-16. PubMed ID: 24456672
    [Abstract] [Full Text] [Related]

  • 39. Nanoformulation and Evaluation of Oral Berberine-Loaded Liposomes.
    Duong TT, Isomäki A, Paaver U, Laidmäe I, Tõnisoo A, Yen TTH, Kogermann K, Raal A, Heinämäki J, Pham TM.
    Molecules; 2021 Apr 29; 26(9):. PubMed ID: 33946815
    [Abstract] [Full Text] [Related]

  • 40. Nimodipine nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies.
    Fu Q, Sun J, Zhang D, Li M, Wang Y, Ling G, Liu X, Sun Y, Sui X, Luo C, Sun L, Han X, Lian H, Zhu M, Wang S, He Z.
    Colloids Surf B Biointerfaces; 2013 Sep 01; 109():161-6. PubMed ID: 23668980
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.